CD8A and neoplasm: More importantly, tumor-derived EVs have been shown to suppress lymphocyte activity, particularly in CD8 T cells (Muller et al., 2016; Ludwig et al., 2017; Maybruck et al., 2017; Dörsam et al., 2018).